• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Smile Train and Wolters Kluwer Health Partner to Empower Global Cleft Care

by Jasmine Pennic 01/29/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Smile Train, the world’s largest cleft-focused organization, and Wolters Kluwer Health, a leading provider of clinical information solutions, have joined forces to bridge this knowledge gap.

– Through their innovative collaboration, Smile Train partners and affiliates globally will gain full online access to select medical journals, empowering them to deliver better cleft care for children in need.

Breaking Down Barriers to Knowledge

Cleft care requires specialized knowledge and access to cutting-edge research. Yet, nearly 71% of Smile Train partners report struggling to access medical journals, hindering their ability to stay informed and deliver the best possible care. This collaboration aims to bridge this gap by providing full online access to select medical journals through Wolters Kluwer’s Ovid® research platform.

Empowering Local Clinicians

Through this initiative, Smile Train partners gain instant access to renowned journals like the New England Journal of Medicine, Plastic and Reconstructive Surgery, and Journal of Craniofacial Surgery. This empowers local clinicians with the latest research and best practices, enabling them to:

  • Improve surgical outcomes: Access to up-to-date knowledge on cleft treatment techniques can lead to better surgical outcomes for children, impacting their speech, breathing, and overall quality of life.
  • Enhance research capabilities: The platform fosters collaboration and knowledge sharing, potentially leading to groundbreaking research in cleft care within these regions.
  • Boost confidence and expertise: Equipped with reliable information, local clinicians can confidently tackle complex cases and provide comprehensive cleft care to more children.

Research Platform for Medical Professionals

Ovid is the go-to research platform for medical professionals worldwide. By offering access to this comprehensive tool, Smile Train is providing its partners with:

  • Thousands of full-text journals and resources: Covering a vast range of medical topics, the platform ensures access to diverse and relevant information.
  • Advanced search and navigation tools: Efficiently finding the information needed for specific cases and research endeavors.
  • Convenient online access: Clinicians can access the platform from anywhere, anytime, regardless of location or resource constraints.

“Medical research continues to expand and grow, with more global contributions happening than ever before. Wolters Kluwer and Smile Train are both dedicated to increasing equity in access to medical literature and publications throughout the world,,” said Rafael Sidi, Senior Vice President & General Manager of Health Research, Wolters Kluwer Health.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |